These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 3226325

  • 21. Evidence for a two-domain structure of the terminal membrane C5b-9 complex of human complement.
    Bhakdi S, Tranum-Jensen J.
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5872-6. PubMed ID: 293689
    [Abstract] [Full Text] [Related]

  • 22. Studies on the mechanism of bacterial resistance to complement-mediated killing. II. C8 and C9 release C5b67 from the surface of Salmonella minnesota S218 because the terminal complex does not insert into the bacterial outer membrane.
    Joiner KA, Hammer CH, Brown EJ, Frank MM.
    J Exp Med; 1982 Mar 01; 155(3):809-19. PubMed ID: 6801180
    [Abstract] [Full Text] [Related]

  • 23. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT, Austen KF, Ruddy S.
    Rheumatology; 1975 Mar 01; 6():2-16. PubMed ID: 1105744
    [No Abstract] [Full Text] [Related]

  • 24. Deviated lysis: transfer of complement lytic activity to unsensitized cells. IV. Parital isolation of the activity.
    Hänsch G, Rother U, Rother K.
    Z Immunitatsforsch Immunobiol; 1977 Apr 01; 153(1):48-59. PubMed ID: 868206
    [Abstract] [Full Text] [Related]

  • 25. On the cause and nature of C9-related heterogeneity of terminal complement complexes generated on target erythrocytes through the action of whole serum.
    Bhakdi S, Tranum-Jensen J.
    J Immunol; 1984 Sep 01; 133(3):1453-63. PubMed ID: 6747293
    [Abstract] [Full Text] [Related]

  • 26. Evidence that C5b recognizes and mediates C8 incorporation into the cytolytic complex of complement.
    Stewart JL, Kolb WP, Sodetz JM.
    J Immunol; 1987 Sep 15; 139(6):1960-4. PubMed ID: 3624872
    [Abstract] [Full Text] [Related]

  • 27. Studies on serum resistance in Escherichia coli.
    Kubens BS, Opferkuch W.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Nov 15; 270(1-2):52-65. PubMed ID: 3146846
    [Abstract] [Full Text] [Related]

  • 28. Formation of complement membrane attack complex in mammalian cerebral cortex evokes seizures and neurodegeneration.
    Xiong ZQ, Qian W, Suzuki K, McNamara JO.
    J Neurosci; 2003 Feb 01; 23(3):955-60. PubMed ID: 12574424
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Penetration of C8 and C9 in the C5b-9 complex across the erythrocyte membrane into the cytoplasmic space.
    Whitlow MB, Ramm LE, Mayer MM.
    J Biol Chem; 1985 Jan 25; 260(2):998-1005. PubMed ID: 2857173
    [Abstract] [Full Text] [Related]

  • 33. Homologous restriction factor: effect on complement C8 and C9 uptake and lysis.
    Zalman LS, Müller-Eberhard H.
    Mol Immunol; 1994 Mar 25; 31(4):301-5. PubMed ID: 8139583
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Immunoenzyme determination of the C5b-9 complex of the complement system].
    Rus H, Niculescu F, Cristea A, Vlaicu R.
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1986 Mar 25; 31(1):35-40. PubMed ID: 3738363
    [No Abstract] [Full Text] [Related]

  • 36. The human complement regulatory protein CD59 binds to the alpha-chain of C8 and to the "b"domain of C9.
    Ninomiya H, Sims PJ.
    J Biol Chem; 1992 Jul 05; 267(19):13675-80. PubMed ID: 1377690
    [Abstract] [Full Text] [Related]

  • 37. Binding of human and rat CD59 to the terminal complement complexes.
    Lehto T, Morgan BP, Meri S.
    Immunology; 1997 Jan 05; 90(1):121-8. PubMed ID: 9038722
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Interactions of soluble CD59 with the terminal complement complexes. CD59 and C9 compete for a nascent epitope on C8.
    Lehto T, Meri S.
    J Immunol; 1993 Nov 01; 151(9):4941-9. PubMed ID: 7691959
    [Abstract] [Full Text] [Related]

  • 40. Complement component C7 is a plasminogen-binding protein.
    Reinartz J, Hänsch GM, Kramer MD.
    J Immunol; 1995 Jan 15; 154(2):844-50. PubMed ID: 7814888
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.